Ly on clinical criteria, there was a selection bias towards more advanced immunodeficiency at baseline, which increases the risk of drug resistance. However, these biases reflect the realities in many African ART programmes.2 ?4,10,11 Finally, this was a cross-sectional survey of patients alive and in care, leaving out a high number of patients who died, were lost to follow-up or transferred out;